Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Sep 29, 2011, 06:09 ET from Reportlinker

NEW YORK, Sept. 29, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

http://www.reportlinker.com/p0648878/Atopic-Dermatitis-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, "Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Atopic Dermatitis Therapeutics market. The report identifies the key trends shaping and driving the global Atopic Dermatitis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Atopic Dermatitis Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Atopic Dermatitis Therapeutics market. Its scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Atopic Dermatitis Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

- Analysis of the current and future competition in the seven key countries Atopic Dermatitis Therapeutics market.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Atopic Dermatitis Therapeutics market.

- Analysis of key recent licensing and partnership agreements in Atopic Dermatitis Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global Atopic Dermatitis Therapeutics market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Atopic Dermatitis Therapeutics market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What's the next big thing in the global Atopic Dermatitis Therapeutics market landscape? – Identify, understand and capitalize.

1 Table of contents

1 Table of contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Atopic Dermatitis - Introduction 7

2.1 Overview 7

2.2 Epidemiology 7

2.3 Etiology 7

2.4 Symptoms 8

2.5 Diagnosis 9

2.6 Pathophysiology 9

2.7 Treatment and Management Pattern 10

2.8 GlobalData Pipeline Report Guidance 13

3 Atopic DermatitisTherapeutics - Market Characterization 14

3.1 Atopic Dermatitis Market Size (2005 - 2010) - Global 14

3.2 Atopic Dermatitis Market Forecast (2010 - 2018) - Global 15

3.3 Atopic Dermatitis Market Size (2005 - 2010) - The US 16

3.4 Atopic Dermatitis Market Forecast (2010 - 2018) - The US 17

3.5 Atopic Dermatitis Market Size (2005 - 2010) - France 18

3.6 Atopic Dermatitis Market Forecast (2010 - 2018) - France 19

3.7 Atopic Dermatitis Market Size (2005 - 2010) - Germany 20

3.8 Atopic Dermatitis Market Forecast (2010 - 2018) - Germany 21

3.9 Atopic Dermatitis Market Size (2005 - 2010) - Italy 22

3.10 Atopic Dermatitis Market Forecast (2010 - 2018) - Italy 23

3.11 Atopic Dermatitis Market Size (2005 - 2010) - Spain 24

3.12 Atopic Dermatitis Market Forecast (2010 - 2018) - Spain 25

3.13 Atopic Dermatitis Market Size (2005 - 2010) - The UK 26

3.14 Atopic Dermatitis Market Forecast (2010 - 2018) - The UK 27

3.15 Atopic Dermatitis Market Size (2005 - 2010) - Japan 28

3.16 Atopic Dermatitis Market Forecast (2010 - 2018) - Japan 29

3.17 Drivers and Barriers for the Atopic Dermatitis Market 30

3.17.1 Drivers for the Atopic Dermatitis Market 30

3.17.2 Barriers for the Atopic Dermatitis Market 30

3.18 Opportunity and Unmet Need 31

3.19 Key Takeaway 32

4 Atopic Dermatitis Market - Competitive Assessment 33

4.1 Overview 33

4.2 Strategic Competitor Assessment 33

4.3 Product Profile for Major Marketed Products in the Atopic Dermatitis Market 34

4.3.1 Protopic (tacrolimus) 34

4.3.2 Elidel (pimecrolimus) 35

4.3.3 MimyX 37

4.3.4 Atopiclair 37

4.3.5 Topical Corticosteroids 38

4.4 Key Takeaway 39

5 Atopic Dermatitis - Pipeline Assessment 40

5.1 Overview 40

5.2 Strategic Pipeline Assessment 40

5.3 Atopic Dermatitis - Pipeline Analysis by Phase of Development 40

5.3.1 Atopic Dermatitis - Filed and Phase III Pipeline 40

5.3.2 Atopic Dermatitis - Phase II Pipeline 41

5.3.3 Atopic Dermatitis - Phase I Pipeline 42

5.3.4 Atopic Dermatitis - Preclinical Pipeline 42

5.4 Atopic Dermatitis - Pipeline by Mechanism of Action 43

5.5 Technology Trends Analytical Framework 44

5.6 Most Promising Drug Profiles 46

5.6.1 LAS 41002 46

5.7 Key Takeaway 47

6 Atopic Dermatitis - Clinical Trials Mapping 48

6.1 Clinical Trials by Region and Country 48

6.2 Clinical Trials by Phase of Clinical Development 49

6.3 Clinical Trials by Trial Status 50

6.4 Clinical Trials by Sponsors 51

6.5 Top Companies Participating in Atopic Dermatitis Clinical Trials 53

7 Atopic Dermatitis Market - Strategic Assessment 54

7.1 Key Events Impacting the Future Market 54

7.2 Future Market Competition Scenario 54

8 Atopic Dermatitis Market - Future Companies 56

8.1 Introduction 56

8.2 Company Profiles 56

8.2.1 Almirall 56

8.2.2 Anacor Pharmaceuticals 57

8.2.3 BioCis Pharmaceuticals 58

8.2.4 MIKA Pharma GmbH 58

8.3 Details of Other Companies in the Pipeline 59

8.4 Key Takeaway 59

9 Atopic Dermatitis - Licensing and Partnership Deals 60

10 Atopic Dermatitis - Appendix 62

10.1 Definitions 62

10.2 Acronyms 62

10.3 Methodology 63

10.3.1 Coverage 63

10.3.2 Secondary Research 64

10.3.3 Forecasting 64

10.3.4 Primary Research 67

10.3.5 Expert Panel Validation 67

10.4 Contact Us 67

10.5 Disclaimer 67

10.6 Bibliography 68

List of Tables

Table 1: Atopic Dermatitis Therapeutics - Treatment Options 11

Table 2: Atopic Dermatitis Therapeutics - Commonly Used Topical Corticosteroids 11

Table 3: Atopic Dermatitis Market, Global, Revenue ($m), 2005 - 2010 14

Table 4: Atopic Dermatitis Market, Global, Forecast ($m), 2010 - 2018 15

Table 5: Atopic Dermatitis Therapeutics Market, The US, Revenue ($m), 2005 - 2010 16

Table 6: Atopic Dermatitis Market, The US, Forecast ($m), 2010 - 2018 17

Table 7: Atopic Dermatitis Market, France, Revenue ($m), 2005 - 2010 18

Table 8: Atopic Dermatitis Market, France, Forecast ($m), 2010 - 2018 19

Table 9: Atopic Dermatitis Market, Germany, Revenue ($m), 2005 - 2010 20

Table 10: Atopic Dermatitis Market, Germany, Forecast ($m), 2010 - 2018 21

Table 11: Atopic Dermatitis Market, Italy, Revenue ($m), 2005 - 2010 22

Table 12: Atopic Dermatitis Market, Italy, Forecast ($m), 2010 - 2018 23

Table 13: Atopic Dermatitis Market, Spain, Revenue ($m), 2005 - 2010 24

Table 14: Atopic Dermatitis Market, Spain, Forecast ($m), 2010 - 2018 25

Table 15: Atopic Dermatitis Market, The UK, Revenue ($m), 2005 - 2010 26

Table 16: Atopic Dermatitis Market, The UK, Forecast ($m), 2010 - 2018 27

Table 17: Atopic Dermatitis Market, Japan, Revenue ($m), 2005 - 2010 28

Table 18: Atopic Dermatitis Market, Japan, Forecast ($m), 2010 - 2018 29

Table 19: Atopic Dermatitis Therapeutics Market, Global, Comparative Study on the Efficacy of Protopic in Phase III Clinical Trials, 2003 35

Table 20: Atopic Dermatitis Therapeutics Market, Global, Comparative Study on the Efficacy of Elidel in Clinical Trials, 1998 - 2002 36

Table 21: Atopic Dermatitis Therapeutics Market, Global, Major Marketed Products Comparison, 2011 39

Table 22: Atopic Dermatitis Therapeutics - Phase III Clinical Pipeline, 2011 40

Table 23: Atopic Dermatitis Therapeutics - Phase II Clinical Pipeline, 2011 41

Table 24: Atopic Dermatitis Therapeutics - Phase I Clinical Pipeline, 2011 42

Table 25: Atopic Dermatitis Therapeutics - Pre-Clinical and Discovery Pipeline, 2011 42

Table 26: LAS 41002 - Clinical Study Details 46

Table 27: Atopic Dermatitis, Global, Clinical Trials, 2011 48

Table 28: Atopic Dermatitis, Global, Clinical Trials by Phase, 2011 49

Table 29: Atopic Dermatitis, Global, Clinical Trials by Status of Development, 2011 50

Table 30: Atopic Dermatitis, Global, Overall Sponsors, 2011 51

Table 31: Atopic Dermatitis, Global, Prominent Sponsors, 2011 52

Table 32: Atopic Dermatitis, Global, Top Ten Companies by Phase, 2011 53

Table 33: Almirall - Dermatology Pipeline Products, 2011 57

Table 34: Anacor Pharmaceuticals - Dermatology Pipeline Products, 2011 57

Table 35: BioCis Pharmaceuticals - Dermatology Pipeline Products, 2011 58

Table 36: MIKA Pharma GmbH - Dermatology Pipeline Products, 2011 58

Table 37: Description of Other Companies in the Pipeline, 2011 59

Table 38: Atopic Dermatitis, Global, Deals, 2011 60

List of Figures

Figure 1: Atopic Dermatitis Therapeutics - Eczematous Skin 7

Figure 2: Atopic Dermatitis - Causes of Atopic Dermatitis 8

Figure 3: Atopic Dermatitis - Sign and Symptoms 8

Figure 4: Atopic Dermatitis - Pathophysiology 9

Figure 5: Atopic Dermatitis - Treatment Algorithm 12

Figure 6: Atopic Dermatitis Therapeutics Market, Global, Revenue ($m), 2005 - 2010 14

Figure 7: Atopic Dermatitis Therapeutics Market, Global, Forecast ($m), 2010 - 2018 15

Figure 8: Atopic Dermatitis Therapeutics Market, The US, Revenue ($m), 2005 - 2010 16

Figure 9: Atopic Dermatitis Therapeutics Market, The US, Forecast ($m), 2010 - 2018 17

Figure 10: Atopic Dermatitis Therapeutics Market, France, Revenue ($m), 2005 - 2010 18

Figure 11: Atopic Dermatitis Therapeutics Market, France, Forecast ($m), 2010 - 2018 19

Figure 12: Atopic Dermatitis Therapeutics Market, Germany , Revenue ($m), 2005 - 2010 20

Figure 13: Atopic Dermatitis Therapeutics Market, Germany, Forecast ($m), 2010 - 2018 21

Figure 14: Atopic Dermatitis Therapeutics Market, Italy, Revenue ($m), 2005 - 2010 22

Figure 15: Atopic Dermatitis Therapeutics Market, Italy, Forecast ($m), 2010 - 2018 23

Figure 16: Atopic Dermatitis Therapeutics Market, Spain, Revenue ($m), 2005 - 2010 24

Figure 17: Atopic Dermatitis Therapeutics Market, Spain, Forecast ($m), 2010 - 2018 25

Figure 18: Atopic Dermatitis Therapeutics Market, The UK, Revenue ($m), 2005 - 2010 26

Figure 19: Atopic Dermatitis Therapeutics Market, The UK, Forecast ($m), 2010 - 2018 27

Figure 20: Atopic Dermatitis Therapeutics Market, Japan, Revenue ($m), 2005 - 2010 28

Figure 21: Atopic Dermatitis Therapeutics Market, Japan, Forecast ($m), 2010 - 2018 29

Figure 22: Opportunity and Unmet Need in the Atopic Dermatitis Therapeutics Market, 2011 31

Figure 23: Strategic Competitor Assessment of the Marketed Products in Atopic Dermatitis Therapeutics, 2011 33

Figure 24: Atopic Dermatitis Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2011 43

Figure 25: Atopic Dermatitis - Clinical Pipeline by Phase of Development (%), 2011 44

Figure 26: Technology Trends Analytics Framework, 2011 44

Figure 27: Technology Trends Analytics Framework - Description, 2011 45

Figure 28: Atopic Dermatitis, Global, Clinical Trials by Country, 2011 48

Figure 29: Atopic Dermatitis, Global, Clinical Trials by Phase (%), 2011 49

Figure 30: Atopic Dermatitis, Global, Clinical Trials by Status of Development (%), 2011 50

Figure 31: Atopic Dermatitis, Global, Overall Sponsors (%), 2011 51

Figure 32: Atopic Dermatitis, Global, Prominent Sponsors (%), 2011 52

Figure 33: Atopic Dermatitis, Global, Top Companies by Phase, 2011 53

Figure 34: Atopic Dermatitis Market, Drivers and Barriers, 2011 54

Figure 35: Implications for Future Market Competition in the Atopic Dermatitis Therapeutics Market, 2011 54

Figure 36: Atopic Dermatitis Market, Clinical Pipeline by Company, 2011 56

Figure 37: GlobalData Market Forecasting Model 66

Companies Mentioned

Almirall

Anacor Pharmaceuticals

BioCis Pharmaceuticals

MIKA Pharma GmbH

To order this report:

Pathology Industry: Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Pathology Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com